81 FR 21885 - Office of the Director, Office of Science Policy, Office of Biotechnology Activities; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 71 (April 13, 2016)

Page Range		21885-21886
FR Document		2016-08437

Federal Register, Volume 81 Issue 71 (Wednesday, April 13, 2016)

[Federal Register Volume 81, Number 71 (Wednesday, April 13, 2016)]
[Notices]
[Pages 21885-21886]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-08437]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Office of Science Policy, Office of 
Biotechnology Activities; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the

[[Page 21886]]

National Science Advisory Board for Biosecurity (NSABB).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: May 24, 2016.
    Time: 8:30 a.m.-4:00 p.m. Eastern.
    Agenda: (1) Finalization of NSABB findings and recommendations 
on a conceptual approach to evaluating proposed gain-of-function 
(GOF) studies; (2) discussion of next steps for U.S. government 
policy development regarding GOF studies; and (3) other business of 
the Board.
    Place: National Institutes of Health, Wilson Hall, 3rd Floor, 
Bldg. 1, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Christopher Viggiani, Ph.D., Executive Director, 
NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 
750, Bethesda, Maryland 20892, (301) 496-9838, [email protected].

    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established the National Science Advisory Board for Biosecurity 
(NSABB) to provide advice regarding federal oversight of dual use 
research--defined as legitimate biological research that generates 
information and technologies that could be misused to pose a 
biological threat to public health and/or national security. The 
NSABB is currently charged with providing formal recommendations to 
the United States Government on a conceptual approach for the 
evaluation of proposed gain-of-function studies.
    The meeting will be open to the public and will also be webcast 
as space will be limited. Persons planning to attend or view via the 
webcast may pre-register online via the link provided below or by 
calling Palladian Partners, Inc. (Contact: Ida Donner or Carly 
Sullivan at 301-273-2817). Online and telephone registration will 
close at 12:00 p.m. Eastern on May 18, 2016. After that time, 
attendees may register onsite on the day of the meeting. Individuals 
who plan to attend and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
indicate these requirements upon registration on or prior to May 18.
    Meeting materials: The meeting agenda and links to the online 
registration and webcast will be available at: http://osp.od.nih.gov/office-biotechnology-activities/biosecurity/nsabb/nsabb-meetings-and-conferences. NSABB findings and draft 
recommendations will be posted prior to the meeting. Please check 
this Web site for updates.
    Public Comments: Time will be allotted on the agenda for the 
presentation of public comments. Members of the public interested in 
presenting prepared comments relevant to the mission of the NSABB 
should indicate so upon registration. Sign-up for delivering 
prepared oral comments will be limited to one per person or 
organization representative per open comment period. Individual 
presentations will be time-limited to facilitate broad participation 
from multiple speakers. Participants viewing the meeting by webcast 
may submit questions and comments during the meeting via email sent 
to [email protected]. While time constraints and the volume of 
questions may not allow for all questions and comments submitted via 
email to be aired during the meeting, all relevant correspondence 
received will be relayed to the Board. Emailed correspondence should 
include the name, contact information, and when applicable, 
professional affiliation of the sender.
    In addition, interested persons may file written comments at any 
time with the Board via an email sent to [email protected] or by 
regular mail sent to the Contact Person listed on this notice. 
Written statements should include the name, contact information, and 
when applicable, the professional affiliation of the interested 
person. Written comments received by 10:00 a.m. Eastern on May 20, 
2016, will be relayed to the Board prior to the NSABB meeting. Any 
written comments received after this deadline will be provided to 
the Board either before or after the meeting, depending on the 
volume of comments received and the time required to process them in 
accordance with privacy regulations and other applicable Federal 
policies.
    Please Note: In the interest of security, NIH has instituted 
stringent procedures for entrance onto the NIH campus. All visitor 
vehicles, including taxis, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors will be asked to 
show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit. Please visit the NIH Visitor Security page for 
important security and campus access information.


    Dated: April 6, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-08437 Filed 4-12-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 71 / Wednesday, April 13, 2016 / Notices 21885

Contact Person: Kausik Ray, Ph.D., as amended. The grant applications and provisions set forth in sections
Scientific Review Officer, National Institute the discussions could disclose 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
on Deafness and Other Communication confidential trade secrets or commercial as amended. The grant applications and
Disorders, National Institutes of Health, property such as patentable material, the discussions could disclose
Rockville, MD 20850, 301–402–3587, rayk@
nidcd.nih.gov. and personal information concerning confidential trade secrets or commercial
individuals associated with the grant property such as patentable material,
Name of Committee: National Institute on
Deafness and Other Communication applications, the disclosure of which and personal information concerning
Disorders Special Emphasis Panel; VSL would constitute a clearly unwarranted individuals associated with the grant
Clinical Trial Review. invasion of personal privacy. applications, the disclosure of which
Date: May 2, 2016. Name of Committee: National Advisory would constitute a clearly unwarranted
Time: 2:00 p.m. to 3:30 p.m. Council on Alcohol Abuse and Alcoholism; invasion of personal privacy.
Agenda: To review and evaluate grant Early Review of Grant Applications.
applications. Name of Committee: National Advisory
Date: April 20, 2016. Eye Council.
Place: National Institutes of Health, Time: 1:00 p.m. to 2:30 p.m.
Neuroscience Center, 6001 Executive Date: June 16, 2016.
Agenda: To review and evaluate grant
Boulevard, Rockville, MD 20852 (Telephone Open: 8:30 a.m. to 1:00 p.m.
applications.
Conference Call). Agenda: Following opening remarks by the
Place: National Institute on Alcohol Abuse
Contact Person: Shiguang Yang, DVM, & Alcoholism, 5635 Fishers Lane, Room Director, NEI, there will be presentations by
Ph.D., Scientific Review Officer, Division of 3002, Rockville, MD 20892, (Telephone the staff of the Institute and discussions
Extramural Activities, NIDCD, NIH, 6001 Conference Call). concerning Institute programs.
Executive Blvd., Room 8349, Bethesda, MD Contact Person: Abraham P. Bautista, Place: National Institutes of Health,
20892, 301–496–8683, yangshi@ Ph.D., Executive Secretary, National Institute Terrace Level Conference Rooms, 5635
nidcd.nih.gov. on Alcohol Abuse & Alcoholism, National Fishers Lane, Bethesda, MD 20892.
Name of Committee: National Institute on Institutes of Health, 5635 Fishers Lane, Room Closed: 1:00 p.m. to 5:00 p.m.
Deafness and Other Communication 2085, Rockville, MD 20852, 301–443–9737, Agenda: To review and evaluate grant
Disorders Special Emphasis Panel; NIDCD bautista@mail.nih.gov. applications.
Clinical Research Center Grant (P50) Review. This notice is being published less than 15 Place: National Institutes of Health,
Date: May 18, 2016. days prior to the meeting due to the timing Terrace Level Conference Rooms, 5635
Time: 11:00 p.m. to 1:30 p.m. limitations imposed by the review and Fishers Lane, Bethesda, MD 20892.
Agenda: To review and evaluate grant funding cycle. Contact Person: Anne E Schaffner, Ph.D.,
applications. (Catalogue of Federal Domestic Assistance Chief, Scientific Review Branch, Division of
Place: National Institutes of Health, Program Nos. 93.271, Alcohol Research Extramural Research National Eye Institute,
Neuroscience Center, 6001 Executive Career Development Awards for Scientists National Institutes of Health, 5635 Fishers
Boulevard, Rockville, MD 20852 (Telephone and Clinicians; 93.272, Alcohol National Lane, Suite 1300, MSC 9300, Bethesda, MD
Conference Call). Research Service Awards for Research 20892–9300, (301) 451–2020, aes@
Contact Person: Shiguang Yang, DVM, Training; 93.273, Alcohol Research Programs; nei.nih.gov.
Ph.D., Scientific Review Officer, Division of 93.891, Alcohol Research Center Grants; Any interested person may file written
Extramural Activities, NIDCD, NIH, 6001 93.701, ARRA Related Biomedical Research comments with the committee by forwarding
Executive Blvd., Room 8349, Bethesda, MD and Research Support Awards, National the statement to the Contact Person listed on
20892, 301–496–8683, yangshi@ Institutes of Health, HHS) this notice. The statement should include the
nidcd.nih.gov. Dated: April 7, 2016. name, address, telephone number and when
(Catalogue of Federal Domestic Assistance applicable, the business or professional
Melanie J. Gray,
Program Nos. 93.173, Biological Research affiliation of the interested person.
Related to Deafness and Communicative Program Analyst, Office of Federal Advisory Information is also available on the
Disorders, National Institutes of Health, HHS) Committee Policy. Institute’s/Center’s home page:
[FR Doc. 2016–08436 Filed 4–12–16; 8:45 am] www.nei.nih.gov, where an agenda and any
Dated: April 8, 2016.
BILLING CODE 4140–01–P additional information for the meeting will
Sylvia L. Neal, be posted when available.
Program Analyst, Office of Federal Advisory (Catalogue of Federal Domestic Assistance
Committee Policy. DEPARTMENT OF HEALTH AND Program Nos. 93.867, Vision Research,
[FR Doc. 2016–08524 Filed 4–12–16; 8:45 am] HUMAN SERVICES National Institutes of Health, HHS)
BILLING CODE 4140–01–P Dated: April 7, 2016.
National Institutes of Health
Natasha M. Copeland,
National Eye Institute; Notice of Program Analyst, Office of Federal Advisory
DEPARTMENT OF HEALTH AND
Meeting Committee Policy.
HUMAN SERVICES
[FR Doc. 2016–08435 Filed 4–12–16; 8:45 am]
Pursuant to section 10(d) of the
National Institutes of Health Federal Advisory Committee Act, as
BILLING CODE 4140–01–P

National Institute on Alcohol Abuse amended (5 U.S.C. App.), notice is
and Alcoholism; Notice of Closed hereby given of a meeting of the DEPARTMENT OF HEALTH AND
Meeting National Advisory Eye Council. HUMAN SERVICES
The meeting will be open to the
Pursuant to section 10(d) of the public as indicated below, with National Institutes of Health
Federal Advisory Committee Act, as attendance limited to space available.
asabaliauskas on DSK3SPTVN1PROD with NOTICES

amended (5 U.S.C. App.), notice is Individuals who plan to attend and Office of the Director, Office of Science
hereby given of a meeting of the need special assistance, such as sign Policy, Office of Biotechnology
National Advisory Council on Alcohol language interpretation or other Activities; Notice of Meeting
Abuse and Alcoholism reasonable accommodations, should
The meeting will be closed to the notify the Contact Person listed below Pursuant to section 10(a) of the
public in accordance with the in advance of the meeting. Federal Advisory Committee Act, as
provisions set forth in sections The meeting will be closed to the amended (5 U.S.C. App.), notice is
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., public in accordance with the hereby given of the meeting of the

VerDate Sep<11>2014 17:41 Apr 12, 2016 Jkt 238001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\13APN1.SGM 13APN1

Document Created: 2016-04-13 03:11:42
Document Modified: 2016-04-13 03:11:42

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		May 24, 2016.
FR Citation		81 FR 21885

81 FR 21885 - Office of the Director, Office of Science Policy, Office of Biotechnology Activities; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 71 (April 13, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health